Gara Jalqabaatti › Sukkaraa Gosa 2 › Ohio › Cincinnati
Qorannoo klinikaalii Sukkaraa Gosa 2 Cincinnati, OH keessatti
Qorannoo 12 Sukkaraa Gosa 2 f Cincinnati fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Namoota walitti qabaa jiraSadarkaa 3
- Velocity Clinical Research - Cincinnati, Cincinnati
- Velocity Clinical Research - Springdale, Cincinnati
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Namoota walitti qabaa jiraSadarkaa 2
- Velocity Clinical Research, Cincinnati, Springdale, Cincinnati
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Namoota walitti qabaa jiraSadarkaa 3
- The Christ Hospital, Cincinnati
- Velocity Clinical Research-Cincinnati-69044, Cincinnati
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Namoota walitti qabaa jiraSadarkaa 3
- Midwest Eye Center, Cincinnati
- Velocity Clinical Research, Mt. Auburn, Cincinnati
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
- St Elizabeth Health Care - CRI, Edgewood · Miili 8 fagaatti
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Namoota walitti qabaa jiraSadarkaa 3
- AURORA-2 Clinical Site, Cincinnati
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Namoota walitti qabaa jiraSadarkaa 2
- Velocity Clinical Research, Cincinnati, Mt. Auburn, Cincinnati
- Velocity Clinical Research - Cincinnati, Blue Ash, Cincinnati
- St. Elizabeth Healthcare, Edgewood · Miili 8 fagaatti
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Cincinnati
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
Namoota walitti qabaa jiraSadarkaa 3
- Univ of Cincinnati Med Cent, Cincinnati
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Namoota walitti qabaa jiraSadarkaa 3
- Childrens Hospital Medical Center, Cincinnati
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
Namoota walitti qabaa jiraQorannoo ilaalaa
- Cincinnati Children's Hospital, Cincinnati
Liraglutide Treatment in Patients With Maturity-onset Diabetes of the Young (MODY)
Namoota walitti qabaa jiraSadarkaa 2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Qorannoo Sukkaraa Gosa 2 magaalota biroo keessatti
- San Antonio, TXQorannoo 37
- Houston, TXQorannoo 31
- Orlando, FLQorannoo 25
- Boston, MAQorannoo 20
- Chicago, ILQorannoo 19
- Dallas, TXQorannoo 19
- Miami, FLQorannoo 19
- Columbus, OHQorannoo 18
- Las Vegas, NVQorannoo 18
- San Diego, CAQorannoo 17
- Atlanta, GAQorannoo 17
- Los Angeles, CAQorannoo 16
Qorannoo biroo Cincinnati keessatti
- Kansara Qara'a Non-Small CellQorannoo 35
- Saree (Gosoota Hunda)Qorannoo 27
- Saree OljooQorannoo 25
- Cufama OnneeQorannoo 24
- Kansarii ColorectalQorannoo 21
- Kansara MetastatikiiQorannoo 21
- Leukemia Myeloidii HamaaQorannoo 20
- Kansarii OvariiQorannoo 19
- ObesityQorannoo 19
- Dhibee QaraQorannoo 19
- Kansarii ProstateQorannoo 18
- MelanomaQorannoo 17
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.